Clinical Trials Logo

Malignant Airway Obstruction clinical trials

View clinical trials related to Malignant Airway Obstruction.

Filter by:
  • None
  • Page 1

NCT ID: NCT04676815 Not yet recruiting - Lung Cancer Clinical Trials

Narrow Band Imaging (NBI) Under Electronic Bronchoscope in Lung Cancer

Start date: June 2023
Phase:
Study type: Observational

Narrow-Band Imaging (NBI) is useful to better demarcate the superficial extent of central type of lung cancer, but its sensitivity and specificity in clinical practice were little studied. This study aimed to investigate the diagnostic effects of NBI in suspected patients with central lung cancer and its application in staging diagnosis of central lung cancer.

NCT ID: NCT03944408 Not yet recruiting - Clinical trials for Malignant Airway Obstruction

A Metal Bare Stent With 125 Iodine (125I)Seeds for the Treatment of Malignant Central Airway Stenosis

Start date: May 2019
Phase: N/A
Study type: Interventional

Malignant central airway stenosis caused by primary or metastatic malignant tumor may lead to dyspnea even death of patients.With the rapid development of interventional pulmonology, bronchoscopic therapy has become the main treatment for malignant central airway stenosis. Metal stent implantation in airway can quickly relieve respiratory obstruction and improve quality of life.However, the tumor tissue can continue to grow into metal stent and obstruct airway again. This is the shortcoming of metal bare stents, which often need further treatment to keep airway open, including ablation, laser, cryotherapy, external radiotherapy or systemic anti-tumor drug therapy.Metal stent implantation combined with external radiotherapy can effectively reduce the incidence of airway restenosis.However, complications of external radiotherapy are high, including bone marrow suppression, radioactive pneumonia, radioactive esophagitis, myocardial injury and tracheoesophageal fistula, of which may cause serious consequences and even cause death of the patient.125I radioactive seeds have been one of the mature radioactive interventional therapy, which release X rays, and γ rays. Because of the short radioactive distance, 125I seeds can destruct tumor cells in tumor site and promote apoptosis and necrosis of tumor cells around the obstruction of the airway, meanwhile cause little damage to the surrounding normal tissues. Some studies showed that 125I seed implantation of lung tumor lesions achieved good short-term results.Therefore, the investigators hypothesize that 125I seeds fixed on the metal bare stent can not only improve the patient's breathing difficulties, but also play a role in killing tumor cells. At present, there have been reports of related clinical cases and monocentric control studies of malignant central airway stenosis treated with the implantation of metal stent with 125I seeds, but there is a lack of multicentric clinical studies with large samples.

NCT ID: NCT02565927 Recruiting - Clinical trials for Malignant Airway Obstruction

A Trail of a Novel Tracheal Radioactive Stent for the Malignant Airway Obstruction

Start date: May 2015
Phase: Phase 2
Study type: Interventional

The aim of this study was to evaluate the safety and effectiveness of an radioactive airway stent loaded with 125I seeds compared to a conventional airway stent in patients with malignant airway obstruction caused by both primary and metastatic malignant tumors.